We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.83%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$42.3B
AUM Growth
+$4.13B
(+11%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
2,012
New
692
Increased
651
Reduced
339
Closed
308
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$362M |
| 2 |
ConocoPhillips
COP
|
+$242M |
| 3 |
IBM
IBM
|
+$231M |
| 4 |
UN
Unilever NV New York Registry Shares
UN
|
+$218M |
| 5 |
Boeing
BA
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$614M |
| 2 |
Visa
V
|
+$424M |
| 3 |
SHPG
Shire pic
SHPG
|
+$417M |
| 4 |
TSMC
TSM
|
+$387M |
| 5 |
Home Depot
HD
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Financials | 11.64% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$473B
| $931M | 2.2% |
3,955,200
-77,997
| -2% | -$16.8M |
|
|
2
Rio Tinto
RIO
$150B
| $761M | 1.8% |
12,926,674
+6,581,224
| +104% | +$362M |
|
3
Bristol-Myers Squibb
BMY
$127B
| $703M | 1.66% |
14,738,676
-26,183
| -0.2% | -$1.3M |
|
|
4
IBM
IBM
$203B
| $691M | 1.63% |
5,119,196
+1,811,543
| +55% | +$231M |
|
5
TJX Companies
TJX
$171B
| $659M | 1.56% |
12,387,698
-1,966,806
| -14% | -$98.1M |
|
6
Merck
MRK
$324B
| $633M | 1.5% |
7,975,969
+1,584,254
| +25% | +$118M |
|
7
iShares MSCI South Korea ETF
EWY
$22.2B
| $624M | 1.48% |
10,241,205
-1,001,559
| -9% | -$62.1M |
|
8
AbbVie
ABBV
$457B
| $557M | 1.32% |
6,915,789
-228,540
| -3% | -$18.7M |
|
|
9
Home Depot
HD
$330B
| $555M | 1.31% |
2,893,103
-1,662,005
| -36% | -$305M |
|
10
Adobe
ADBE
$88.6B
| $549M | 1.3% |
2,061,971
-454,522
| -18% | -$115M |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $548M | 1.3% |
5,807,890
+168,377
| +3% | +$14.7M |
|
12
HCA Healthcare
HCA
$85.5B
| $527M | 1.25% |
4,039,369
-31,100
| -0.8% | -$4.18M |
|
13
Intel
INTC
$480B
| $508M | 1.2% |
9,459,334
+426,404
| +5% | +$21.6M |
|
14
AstraZeneca
AZN
$261B
| $504M | 1.19% |
6,229,684
+376,059
| +6% | +$29.6M |
|
|
15
Boeing
BA
$167B
| $504M | 1.19% |
1,320,291
+540,335
| +69% | +$208M |
|
|
16
Visa
V
$673B
| $470M | 1.11% |
3,007,462
-2,945,478
| -49% | -$424M |
|
17
Novartis
NVS
$295B
| $450M | 1.06% |
5,224,226
+1,579,113
| +43% | +$127M |
|
18
GSK
GSK
$103B
| $427M | 1.01% |
8,177,026
+1,372,258
| +20% | +$68.6M |
|
19
UnitedHealth
UNH
$383B
| $427M | 1.01% |
1,727,299
+32,625
| +2% | +$8.32M |
|
20
Biogen
BIIB
$30B
| $406M | 0.96% |
1,716,590
+192,501
| +13% | +$60.6M |
|
21
Union Pacific
UNP
$183B
| $382M | 0.9% |
2,282,754
-148,139
| -6% | -$23.8M |
|
22
Intuit
INTU
$80.1B
| $364M | 0.86% |
1,391,021
-232,768
| -14% | -$53.8M |
|
23
Automatic Data Processing
ADP
$99.2B
| $348M | 0.82% |
2,179,399
-562,096
| -21% | -$81.7M |
|
|
NVO
24
Novo Nordisk
NVO
$217B
| $330M | 0.78% |
12,617,130
-545,596
| -4% | -$13.4M |
|
25
Canadian National Railway
CNI
$78.8B
| $327M | 0.77% |
3,656,277
+74,635
| +2% | +$6.26M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Arrowstreet Capital held 2,012 positions worth $42.3B, up 11% from $38.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital's Q1 2019 filing shows 692 new, 651 increased, 339 reduced and 308 closed positions. Its largest new stake was Philip Morris: 1,468,877 shares worth $130M. The largest sale was Microsoft, an estimated $614M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Arrowstreet Capital's largest Q1 2019 buy was Philip Morris: 1,468,877 shares worth $130M.
- Arrowstreet Capital added most to Rio Tinto in Q1 2019, an estimated $362M increase.
- Arrowstreet Capital's biggest Q1 2019 reduction was Microsoft, cutting an estimated $614M.
- Arrowstreet Capital fully exited Shire pic in Q1 2019, selling an estimated $417M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $42.3B portfolio in Q1 2019.
- Arrowstreet Capital opened 692 new positions and closed 308 in Q1 2019.
- Arrowstreet Capital's portfolio value rose 11% quarter-over-quarter to $42.3B.
Based on Arrowstreet Capital's 13F filing for Q1 2019, filed 15 May 2019.